Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Sequential Q- and Acridine orange-marker technique.

N Niikawa, T Kajii

    Humangenetik
    |October 20, 1975
    PubMed
    Summary
    This summary is machine-generated.

    A novel dual staining method using quinacrine (Q) and acridine orange (AO) fluorescence allows for precise chromosome identification. This technique aids in determining the origin of chromosomal abnormalities like trisomy 22.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Delineation of clinical features in Wiedemann-Steiner syndrome caused by KMT2A mutations.

    Clinical genetics·2015
    Same author

    Down-regulation of ABCC11 protein (MRP8) in human breast cancer.

    Experimental oncology·2011
    Same author

    BubR1 localizes to centrosomes and suppresses centrosome amplification via regulating Plk1 activity in interphase cells.

    Oncogene·2009
    Same author

    Lack of C20orf133 and FLRT3 mutations in 43 patients with Kabuki syndrome in Japan.

    Journal of medical genetics·2008
    Same author

    A novel missense mutation in Van der Woude syndrome: usefulness of fingernail DNA for genetic analysis.

    Journal of dental research·2006
    Same author

    Patched homologue 1 mutations in four Japanese families with basal cell nevus syndrome.

    Journal of clinical pathology·2006
    Same journal

    DNA replication patterns of human C group chromosomes from fibroblasts and amniotic fluid cells revealed by a Giemsa staining technique.

    Humangenetik·1975
    Same journal

    Cytological and cytogenetical studies on brain tumors. VI. No evidence for a translocation in 22-monosomic meningiomas.

    Humangenetik·1975
    Same journal

    Climate associated variations in the human serum albumin level.

    Humangenetik·1975
    Same journal

    A technique for in situ karyotyping of primary amniotic fluid cell cultures.

    Humangenetik·1975
    Same journal

    Sister chromatid exchanges and chromatid interchanges in bloom's syndrome.

    Humangenetik·1975
    Same journal

    Trisomy 9p due to paternal translocation, t(9;13) (q13;q12).

    Humangenetik·1975
    See all related articles

    Area of Science:

    • Cytogenetics
    • Molecular Biology
    • Genetics

    Background:

    • Accurate chromosome identification is crucial for diagnosing genetic disorders.
    • Existing staining techniques may have limitations in differentiating specific chromosomal regions.

    Purpose of the Study:

    • To describe a standardized dual marker technique combining Q- and acridine orange (AO)-fluorescence staining.
    • To demonstrate the utility of this technique in identifying chromosomal origins.

    Main Methods:

    • Preservation of unstained chromosome slides.
    • Sequential Q-staining, destaining, and specific heat/pH treatment.
    • Acridine orange (AO) staining.

    Main Results:

    • Q-markers identified in paracentromeric regions of chromosomes 3 and 4, and on acrocentric chromosome arms/satellites.

    Related Experiment Videos

  • AO-marker spots localized to the satellite-stalks of acrocentric chromosomes.
  • Successfully determined the origin of trisomy 22 in a spontaneous abortus using the dual marker technique.

    • Conclusions:

    • The Q- and AO-fluorescence dual marker technique provides enhanced resolution for chromosome analysis.
    • This method offers a significant advantage for pinpointing the origin of aneuploidies, such as trisomy 22.